#federaldepopulationagency
Ready to Rubber Stamp ANOTHER Moderna mRNA Bioweapon
Today's strong Phase 3 efficacy results are a significant milestone: "An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, & pave the way for COVID-19 “COMBINATION Bioweapons”
News Release
News Release




















